Posttraumatic Stress Disorder (PTSD) Clinical Trial
— CPT4SyriansOfficial title:
Cognitive Processing Therapy for the Treatment of Post-Traumatic Stress Disorder in Syrian Patients
Verified date | September 2021 |
Source | British University In Egypt |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Background: Studies among Syrian refugees showed high prevalence rates of PTSD. The objective of the present study was to investigate the effectiveness of Cognitive Processing Therapy (CPT) in treating patients with posttraumatic stress disorder (PTSD) using a clinical trial. Methods: Data will be obtained through interviewing patients seeking for PTSD treatment. Patients will be interviewed by a clinician and asked to complete the Clinician-Administered PTSD Scale (CAPS-5), Beck Depression Inventory (BDI-II), Beck Anxiety Inventory (BAI). Assessments will be conducted at baseline, 3-, and 12-months posttreatment. The primary outcomes will be the scores of CAPS, BDI-II, and BAI. Results: we predict that CPT will result in greater reductions in CAPS scores.
Status | Completed |
Enrollment | 94 |
Est. completion date | January 1, 2021 |
Est. primary completion date | December 1, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria Their nationalities are Syrians - age older than 18 years and younger than 65, - patients meeting current diagnostic criteria for PTSD as defined in DSM-5 - have a good knowledge of English-language (reading, writing, and comprehension) because all assessments and therapy materials were in English Exclusion Criteria - having mental retardation - having schizophrenia (or any other psychotic disorders). |
Country | Name | City | State |
---|---|---|---|
Egypt | The British university in Egypt | Cairo |
Lead Sponsor | Collaborator |
---|---|
British University In Egypt |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | assessing change in CAPS-5 scores between three time points | Clinician-Administered PTSD Scale (CAPS-5; Weathers et al., 2015) is currently the gold- standard assessment for PTSD and is used to assess PTSD's symptoms at pre-intervention, immediately post- intervention, and 12-month after the intervention. This 30-item structured interview was developed by staff at the U.S. Department of Veterans Affairs National Center for PTSD. The interview can generally be administered in 45-60 minutes. Each question in CAPS asks about both the frequency and the severity of each PTSD symptom. These questions are split into categories. Each criterion has several questions, and scores for each criterion are added up at the end. The CAPS-5 has demonstrated strong psychometric properties (Weathers, et al., 2018). | baseline (pre-intervention), posttreatment (immediately after the intervention), 12-months after the intervention | |
Secondary | assessing change in Beck Depression Inventory (BDI-II) scores between three time points | Beck Depression Inventory (BDI-II): was used to evaluate the change in the severity of depressive symptoms between three time points. BDI-II is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression (Beck, et al., 1996). The BDI takes approximately 10 minutes to complete. Depression levels were defined as follows: minimal range = 0- 13, mild depression = 14-19, moderate depression = 20-28, and severe depression = 29- 63. | baseline (pre-intervention), posttreatment (immediately after the intervention), 12-months after the intervention | |
Secondary | assessing change in Beck Anxiety Inventory (BAI) scores between three time points | Beck Anxiety Inventory (BAI): was used to evaluate the change in the severity of anxiety severity between three time points.
BAI was developed by Dr. Aaron T. Beck and it is a brief measure of anxiety with a focus on somatic symptoms of anxiety such as nervousness, dizziness, inability to relax (Beck et al., 1988). It has a total of 21 items that takes approximately 10-15 minutes to complete. Answers are on a 4-point Likert scale and range from 0 (not at all) to 3 (severely). The values for each item are summed yielding an overall or total score for all 21 symptoms that can range between 0 and 63 points. A total score of 0 - 7 is interpreted as a "Minimal" level of anxiety; 8 - 15 as "Mild"; 16 -25 as "Moderate", and 26 - 63 as "Severe". |
baseline (pre-intervention), posttreatment (immediately after the intervention), 12-months after the intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01443182 -
Treatment of Posttraumatic Stress Disorder (PTSD) in Adult Survivors of Early Chronic Interpersonal Trauma
|
N/A | |
Completed |
NCT01507948 -
Brain Imaging of Psychotherapy for Posttraumatic Stress Disorder (PTSD)
|
N/A | |
Completed |
NCT02911285 -
NAC for Treating Comorbid PTSD and SUD
|
Phase 2 | |
Recruiting |
NCT02234076 -
A Study on the Efficacy of Virtual Reality Exposure Therapy (VRET) for Survivors of Childhood Sexual Abuse and War Related Trauma
|
N/A | |
Completed |
NCT01729026 -
A Study of Dog Adoption in Veterans With Posttraumatic Stress Disorder (PTSD)
|
Early Phase 1 | |
Completed |
NCT01406834 -
Treatment for the Mental Health Impact of Killing in War
|
N/A | |
Completed |
NCT01446146 -
Increasing Engagement in PTSD Treatment Through Patient Education and Patient Choice
|
N/A | |
Completed |
NCT01464892 -
Imagery Rescripting in the Treatment of Post Traumatic Stress Disorder (PTSD) Following Early Chronic Interpersonal Trauma
|
N/A | |
Active, not recruiting |
NCT03283163 -
Neurobiological and Psychological Benefits of Exercise in Chronic Pain and PTSD
|
N/A | |
Completed |
NCT02442843 -
Non Invasive Brain Stimulation for PTSD
|
Early Phase 1 | |
Completed |
NCT01888653 -
Attention-Bias Modification Treatment for PTSD
|
N/A | |
Completed |
NCT01474057 -
DElivery of Self Training and Education for Stressful Situations-Primary Care Version
|
Phase 2 | |
Completed |
NCT00672776 -
Effects of Paxil CR on Neural Circuits in Posttraumatic Stress Disorder (PTSD)
|
Phase 4 | |
Completed |
NCT03641924 -
Cognition and Psychotherapy in PTSD
|
||
Completed |
NCT02397889 -
Ketamine as a Treatment for Post-Traumatic Stress Disorder (PTSD)
|
Phase 2/Phase 3 | |
Completed |
NCT02322047 -
Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders
|
Phase 2 | |
Completed |
NCT00320138 -
Acupuncture for the Treatment of Posttraumatic Stress Among Military Personnel
|
Phase 1 | |
Recruiting |
NCT03833453 -
Effectiveness of PTSD-treatment Compared to Integrated PTSD-PD-treatment in Adult Patients With Comorbid PTSD and BPD
|
N/A | |
Completed |
NCT03833531 -
Effectiveness of PTSD-treatment Compared to Integrated PTSD-PD-treatment in Adult Patients With Comorbid PTSD and CPD
|
N/A | |
Completed |
NCT03529435 -
Project Remission: Maximizing Outcomes With Intensive Treatments for Combat-Related PTSD
|
N/A |